Interestingly, tocilizumab-treated patients acquired strong negative correlation between the transcription of UCP1 and ABCA1 (r = −0.63, p = 0.024), which did not exist in RA patients treated with other anti-rheumatic drugs (r = 0.03). The gene discussed is ABCA1; the disease is rheumatoid arthritis.